News / Health & Wellness
Mesothelioma Alert: Second Annual WIN Symposium to present breakthrough scientific technologies and accomplishments in personalized cancer medicine
Academia and industry unite to improve early cancer diagnosis from July 7th to the 9th, 2010
The Annual WIN Symposium is organized by the WIN Consortium, a gathering of leading, international cancer care institutions, such as the University of Texas’ MD Anderson Cancer Center and the Institut Gustave Roussy. In the words of its co-coordinator Vladimir Lazar, the consortium “is dedicated toensuring rapid translation of ground-breaking personalized cancer medicine discoveries from the bench to the bedside.”
The WIN Symposium will be presenting breakthrough scientific technologies and accomplishments in personalized cancer medicine at the Palais des Congrès in Paris from July 7-9, 2010. Experts in oncology such as physicians, scientists, cancer researchers, pharmaceutical and biotechnology companies, healthcare organizations and patient advocates are expected to participate.
The symposium aims to foster collaboration between the academic and industrial communities by giving them the opportunity to discuss the latest advances in personalized medical treatment for cancer, early diagnosis and rapid transfer of scientific discoveries into clinical practice. Its innovative approach includes oral presentations, poster sessions and an open interactive forum with prominent opinion leaders.
A recurring forum theme is the treatment of mesothelioma. Malignant mesothelioma is a rare type of cancer affecting the lining of the chest and/or abdomen. Those with exposure to airborne asbestos particles are more likely to develop the mesothelioma disease. Mesothelioma treatmenttypically includes surgery, radiation therapy, chemotherapy or a combination of the three.
Though mesothelioma is amongst the hardest cancers to cure, this hasn’t prevented the MD Anderson Cancer Center from taking a proactive approach to mesothelioma treatment. Not only does the Center stand as a privileged partner at the symposium, but it also attracts some of the best mesothelioma doctors in the world.
According to U.S. News and Reports’ “America’s Best Hospitals 2009” list, the MD Anderson Cancer Center is the best hospital in the nation for cancer care. Its mission is simple yet straightforward: to eliminate cancer in Texas, the nation and the world.
Some of the key speakers at this year’s WIN Symposium include:
Leroy Hood, Institute for Systems Biology, Seattle, USA
“The shift from the past to the future of modern oncology. The P4 integrative machine.”
Olli Kallioniemi, Institute for Molecular Medicine (FIMM), University of Helsinki, Finland
“Combining multiple high-throughput technologies in cancer diagnostics and therapy selection.”
Richard Schilsky, University of Chicago Medical Center, Chicago, USA
“The right drug for the right patient at the right time: what remains to be done? WIN Consortium goals.”
Stanley Hamilton, UT-MD Anderson Cancer Center, Houston, USA
“Societal challenges of personalized medicine: the need for a new organization. Who will pay for the next generation of tools and biology-driven medicine?”
For additional information, please visit the symposium’s Web page:
Please call, fax or email MF Congrès with enquiries:
Telephone: +33 (0)1 40 07 11 21 Fax: +33 (0)1 40 07 10 94 info@mfcongres.com www.mfcongres.com
For additional information on the MD Anderson Cancer Center, visit its Web site at:
http://www.mdanderson.org/
